<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39458151</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Secondary Bacterial Infections in Critically Ill COVID-19 Patients Admitted in the Intensive Care Unit of a Tertiary Hospital in Romania.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6201</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13206201</ELocationID><Abstract><AbstractText><b>Background:</b> The outbreak of the COVID-19 pandemic caught healthcare systems in many countries unprepared. Shortages of personnel, medicines, disinfectants, and intensive care unit (ICU) capacities, combined with inadvertent use of antibiotics and emergence of drug-resistant secondary infections, led to a surge in COVID-19-related mortality. <b>Objective:</b> We aimed to evaluate the prevalence of secondary bacterial infections and the associated antibiotic resistance in a temporary established ICU dedicated to COVID-19 patients. We also assessed the utility of clinical and routine laboratory data as predictors of secondary infections and mortality in these patients. <b>Methods:</b> We examined the medical records of 243 patients admitted to the COVID-19 Medical Support Unit of Târgu Mures, Romania, between 1 August 2020 and 31 January 2021. <b>Results:</b> Among the 243 patients admitted to the COVID-19 Medical Support Unit of Târgu Mures between 1 August 2020 and 31 January 2021, 59 (24.3%) presented secondary infections. <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> were the most frequent isolates (31.1% and 18.9%, respectively), most of them multidrug resistant. Chronic obstructive pulmonary disease had a higher prevalence in patients who developed secondary infections (<i>p</i> = 0.012). Secondary infections were associated with longer stay in the ICU and with higher mortality (<i>p</i> = 0.006 and <i>p</i> = 0.038, respectively). <b>Conclusions:</b> Early identification of secondary infections and proper use of antibiotics are necessary to limit the spread of multidrug-resistant microorganisms in COVID-19 patients admitted in the ICU.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pintea-Simon</LastName><ForeName>Ionela-Anca</ForeName><Initials>IA</Initials><Identifier Source="ORCID">0000-0001-8276-444X</Identifier><AffiliationInfo><Affiliation>Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine M3, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bancu</LastName><ForeName>Ligia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine M3, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mare</LastName><ForeName>Anca Delia</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Microbiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciurea</LastName><ForeName>Cristina Nicoleta</ForeName><Initials>CN</Initials><Identifier Source="ORCID">0000-0003-2262-7456</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toma</LastName><ForeName>Felicia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Microbiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brukner</LastName><ForeName>Mădălina Cristina</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Văsieșiu</LastName><ForeName>Anca-Meda</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-2880-4337</Identifier><AffiliationInfo><Affiliation>Department of Infectious Disease, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5281-0601</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">antibiotic resistance</Keyword><Keyword MajorTopicYN="N">pneumonia</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39458151</ArticleId><ArticleId IdType="pmc">PMC11508343</ArticleId><ArticleId IdType="doi">10.3390/jcm13206201</ArticleId><ArticleId IdType="pii">jcm13206201</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zaim S., Chong J.H., Sankaranarayanan V., Harky A. COVID-19 and Multiorgan Response. Curr. Probl. Cardiol. 2020;45:100618. doi: 10.1016/j.cpcardiol.2020.100618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100618</ArticleId><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Contou D., Claudinon A., Pajot O., Micaëlo M., Longuet Flandre P., Dubert M., Cally R., Logre E., Fraissé M., Mentec H., et al. Bacterial and Viral Co-Infections in Patients with Severe SARS-CoV-2 Pneumonia Admitted to a French ICU. Ann. Intensive Care. 2020;10:119. doi: 10.1186/s13613-020-00736-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00736-x</ArticleId><ArticleId IdType="pmc">PMC7475952</ArticleId><ArticleId IdType="pubmed">32894364</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho F.M., Lemos L.N., Ciapina L.P., Moreira R.G., Gerber A., Guimarães A.P.C., Fereguetti T., de Andrade Zambelli V.A., Avila R., de Almeida T.B., et al. Prevalence of Bacterial Pathogens and Potential Role in COVID-19 Severity in Patients Admitted to Intensive Care Units in Brazil. Cold Spring Harbor Laboratory; Cold Spring Harbor, NY, USA: 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.22.20248501</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttner B.D., Catho G., Pano-Pardo J.R., Pulcini C., Schouten J. COVID-19: Don’t Neglect Antimicrobial Stewardship Principles! Clin. Microbiol. Infect. 2020;26:808–810. doi: 10.1016/j.cmi.2020.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7190532</ArticleId><ArticleId IdType="pubmed">32360446</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann C.J., Pho M.T., Pitrak D., Ridgway J.P., Pettit N.N. Community-Acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience. Clin. Infect. Dis. 2020;72:1450–1452. doi: 10.1093/cid/ciaa902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa902</ArticleId><ArticleId IdType="pmc">PMC7337635</ArticleId><ArticleId IdType="pubmed">32604413</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D.R., Soucy J.-P.R., Daneman N. Bacterial Co-Infection and Secondary Infection in Patients with COVID-19: A Living Rapid Review and Meta-Analysis. Clin. Microbiol. Infect. 2020;26:1622–1629. doi: 10.1016/j.cmi.2020.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.016</ArticleId><ArticleId IdType="pmc">PMC7832079</ArticleId><ArticleId IdType="pubmed">32711058</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Simeonova M., Leung V., Lo J., Kan T., Raybardhan S., Sapin M.E., Mponponsuo K., Farrell A., et al. Antimicrobial Resistance in Patients with COVID-19: A Systematic Review and Meta-Analysis. Lancet Microbe. 2023;4:e179–e191. doi: 10.1016/S2666-5247(22)00355-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00355-X</ArticleId><ArticleId IdType="pmc">PMC9889096</ArticleId><ArticleId IdType="pubmed">36736332</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisini A., Boni S., Vacca E.B., Bobbio N., Puente F.D., Feasi M., Prinapori R., Lattuada M., Sartini M., Cristina M.L., et al. Impact of the COVID-19 Pandemic on Epidemiology of Antibiotic Resistance in an Intensive Care Unit (ICU): The Experience of a North-West Italian Center. Antibiotics. 2023;12:1278. doi: 10.3390/antibiotics12081278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12081278</ArticleId><ArticleId IdType="pmc">PMC10451647</ArticleId><ArticleId IdType="pubmed">37627698</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebisi Y.A., Jimoh N.D., Ogunkola I.O., Uwizeyimana T., Olayemi A.H., Ukor N.A., Lucero-Prisno D.E. The Use of Antibiotics in COVID-19 Management: A Rapid Review of National Treatment Guidelines in 10 African Countries. Trop. Med. Health. 2021;49:51. doi: 10.1186/s41182-021-00344-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41182-021-00344-w</ArticleId><ArticleId IdType="pmc">PMC8220112</ArticleId><ArticleId IdType="pubmed">34162445</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Raybardhan S., Leung V., Soucy J.-P.R., Westwood D., Daneman N., MacFadden D.R. Antibiotic Prescribing in Patients with COVID-19: Rapid Review and Meta-Analysis. Clin. Microbiol. Infect. 2021;27:520–531. doi: 10.1016/j.cmi.2020.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.018</ArticleId><ArticleId IdType="pmc">PMC7785281</ArticleId><ArticleId IdType="pubmed">33418017</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengoechea J.A., Bamford C.G.G. SARS-CoV-2, Bacterial Co-Infections, and AMR: The Deadly Trio in COVID-19? EMBO Mol. Med. 2020;12:e12560. doi: 10.15252/emmm.202012560.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202012560</ArticleId><ArticleId IdType="pmc">PMC7283846</ArticleId><ArticleId IdType="pubmed">32453917</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L., Lim B., Baskaran V., Lim W.S. Co-Infections in People with COVID-19: A Systematic Review and Meta-Analysis. J. Infect. 2020;81:266–275. doi: 10.1016/j.jinf.2020.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.046</ArticleId><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson T.M., Moore L.S.P., Zhu N., Ranganathan N., Skolimowska K., Gilchrist M., Satta G., Cooke G., Holmes A. Bacterial and Fungal Coinfection in Individuals with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescribing. Clin. Infect. Dis. 2020;71:2459–2468. doi: 10.1093/cid/ciaa530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa530</ArticleId><ArticleId IdType="pmc">PMC7197596</ArticleId><ArticleId IdType="pubmed">32358954</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudi H. Bacterial Co-Infections and Antibiotic Resistance in Patients with COVID-19. GMS Hyg. Infect. Control. 2020;15:Doc35. doi: 10.3205/dgkh000370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3205/dgkh000370</ArticleId><ArticleId IdType="pmc">PMC7747008</ArticleId><ArticleId IdType="pubmed">33391970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu C., Singh S., Pathak A., Singh S., Patel S.S., Ghoshal U., Garg A. Bacterial Coinfections in COVID: Prevalence, Antibiotic Sensitivity Patterns and Clinical Outcomes from a Tertiary Institute of Northern India. J. Fam. Med. Prim. Care. 2022;11:4473–4478. doi: 10.4103/jfmpc.jfmpc_41_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_41_22</ArticleId><ArticleId IdType="pmc">PMC9638600</ArticleId><ArticleId IdType="pubmed">36353034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141–154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdan I., Gadela T., Bratosin F., Dumitru C., Popescu A., Horhat F.G., Negrean R.A., Horhat R.M., Mot I.C., Bota A.V., et al. The Assessment of Multiplex PCR in Identifying Bacterial Infections in Patients Hospitalized with SARS-CoV-2 Infection: A Systematic Review. Antibiotics. 2023;12:465. doi: 10.3390/antibiotics12030465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12030465</ArticleId><ArticleId IdType="pmc">PMC10044563</ArticleId><ArticleId IdType="pubmed">36978332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., Zhou X., Du C., et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180:934–943. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Yang B., Li Q., Wen L., Zhang R. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin. Infect. Dis. 2020;71:769–777. doi: 10.1093/cid/ciaa272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa272</ArticleId><ArticleId IdType="pmc">PMC7184452</ArticleId><ArticleId IdType="pubmed">32176772</ArticleId></ArticleIdList></Reference><Reference><Citation>International Standard. Medical Laboratories—Requirements for Quality and Competence. ISO; Geneva, Switzerland: 2022.  [(accessed on 29 September 2024)].  Available online:  https://www.iso.org/standard/76677.html.</Citation></Reference><Reference><Citation>EUCAST: AST of Bacteria.  [(accessed on 29 September 2024)].  Available online:  https://www.eucast.org/ast_of_bacteria.</Citation></Reference><Reference><Citation>Zhu N.J., Rawson T.M., Mookerjee S., Price J.R., Davies F., Otter J., Aylin P., Hope R., Gilchrist M., Shersing Y., et al. Changing Patterns of Bloodstream Infections in the Community and Acute Care Across 2 Coronavirus Disease 2019 Epidemic Waves: A Retrospective Analysis Using Data Linkage. Clin. Infect. Dis. 2022;75:e1082–e1091. doi: 10.1093/cid/ciab869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab869</ArticleId><ArticleId IdType="pmc">PMC9402624</ArticleId><ArticleId IdType="pubmed">34596212</ArticleId></ArticleIdList></Reference><Reference><Citation>Damonti L., Kronenberg A., Marschall J., Jent P., Sommerstein R., De Kraker M.E.A., Harbarth S., Gasser M., Buetti N. The Effect of the COVID-19 Pandemic on the Epidemiology of Positive Blood Cultures in Swiss Intensive Care Units: A Nationwide Surveillance Study. Crit. Care. 2021;25:403. doi: 10.1186/s13054-021-03814-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03814-z</ArticleId><ArticleId IdType="pmc">PMC8607066</ArticleId><ArticleId IdType="pubmed">34809698</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll M., Stevens M., Bearman G. Environmental Cleaning and Disinfection of Patient Areas. Int. J. Infect. Dis. 2018;67:52–57. doi: 10.1016/j.ijid.2017.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2017.10.014</ArticleId><ArticleId IdType="pubmed">29102556</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A., Cereda D., Coluccello A., Foti G., Fumagalli R., et al. Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574. doi: 10.1001/jama.2020.5394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Buehler P.K., Zinkernagel A.S., Hofmaenner D.A., Wendel Garcia P.D., Acevedo C.T., Gómez-Mejia A., Mairpady Shambat S., Andreoni F., Maibach M.A., Bartussek J., et al. Bacterial Pulmonary Superinfections Are Associated with Longer Duration of Ventilation in Critically Ill COVID-19 Patients. Cell Rep. Med. 2021;2:100229. doi: 10.1016/j.xcrm.2021.100229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100229</ArticleId><ArticleId IdType="pmc">PMC7955928</ArticleId><ArticleId IdType="pubmed">33748789</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Ling Y., Bai T., Xie Y., Huang J., Li J., Xiong W., Yang D., Chen R., Lu F., et al. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am. J. Respir. Crit. Care Med. 2020;201:1380–1388. doi: 10.1164/rccm.202002-0445OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202002-0445OC</ArticleId><ArticleId IdType="pmc">PMC7258639</ArticleId><ArticleId IdType="pubmed">32275452</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vidal C., Sanjuan G., Moreno-García E., Puerta-Alcalde P., Garcia-Pouton N., Chumbita M., Fernandez-Pittol M., Pitart C., Inciarte A., Bodro M., et al. Incidence of Co-Infections and Superinfections in Hospitalized Patients with COVID-19: A Retrospective Cohort Study. Clin. Microbiol. Infect. 2021;27:83–88. doi: 10.1016/j.cmi.2020.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.041</ArticleId><ArticleId IdType="pmc">PMC7836762</ArticleId><ArticleId IdType="pubmed">32745596</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasero D., Cossu A.P., Terragni P. Multi-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19. Microorganisms. 2021;9:1773. doi: 10.3390/microorganisms9081773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081773</ArticleId><ArticleId IdType="pmc">PMC8402127</ArticleId><ArticleId IdType="pubmed">34442852</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., Wolff M., Spencer R.C., Hemmer M. The Prevalence of Nosocomial Infection in Intensive Care Units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995;274:639–644. doi: 10.1001/jama.1995.03530080055041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1995.03530080055041</ArticleId><ArticleId IdType="pubmed">7637145</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva D.L., Lima C.M., Magalhães V.C.R., Baltazar L.M., Peres N.T.A., Caligiorne R.B., Moura A.S., Fereguetti T., Martins J.C., Rabelo L.F., et al. Fungal and Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients. J. Hosp. Infect. 2021;113:145–154. doi: 10.1016/j.jhin.2021.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8056850</ArticleId><ArticleId IdType="pubmed">33852950</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Hua M., Liu X., Du C., Pu L., Xiang P., Wang L., Liu J. Bacterial and Fungal Co-Infections among COVID-19 Patients in Intensive Care Unit. Microbes Infect. 2021;23:104806. doi: 10.1016/j.micinf.2021.104806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2021.104806</ArticleId><ArticleId IdType="pmc">PMC7933791</ArticleId><ArticleId IdType="pubmed">33684520</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifipour E., Shams S., Esmkhani M., Khodadadi J., Fotouhi-Ardakani R., Koohpaei A., Doosti Z., Ej Golzari S. Evaluation of Bacterial Co-Infections of the Respiratory Tract in COVID-19 Patients Admitted to ICU. BMC Infect. Dis. 2020;20:646. doi: 10.1186/s12879-020-05374-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05374-z</ArticleId><ArticleId IdType="pmc">PMC7461753</ArticleId><ArticleId IdType="pubmed">32873235</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wang J., Yang Y., Cai P., Cao J., Cai X., Zhang Y. Etiology and Antimicrobial Resistance of Secondary Bacterial Infections in Patients Hospitalized with COVID-19 in Wuhan, China: A Retrospective Analysis. Antimicrob. Resist. Infect. Control. 2020;9:153. doi: 10.1186/s13756-020-00819-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-020-00819-1</ArticleId><ArticleId IdType="pmc">PMC7506844</ArticleId><ArticleId IdType="pubmed">32962731</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebreda-Mayoral T., Miguel-Gómez M.A., March-Rosselló G.A., Puente-Fuertes L., Cantón-Benito E., Martínez-García A.M., Muñoz-Martín A.B., Orduña-Domingo A. Infección Bacteriana/Fúngica En Pacientes con COVID-19 Ingresados en un Hospital de Tercer Nivel de Castilla y León, España. Enferm. Infecc. Microbiol. Clin. 2020;40:158–165. doi: 10.1016/j.eimc.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7713607</ArticleId><ArticleId IdType="pubmed">33413990</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebold N., Alosaimy S., Morrisette T., Holger D., Lagnf A.M., Ansari I., Belza A.C., Cheaney L., Hussain H., Herbin S.R., et al. Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19. Infect. Dis. Ther. 2022;11:1281–1296. doi: 10.1007/s40121-022-00636-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-022-00636-6</ArticleId><ArticleId IdType="pmc">PMC9090596</ArticleId><ArticleId IdType="pubmed">35538335</ArticleId></ArticleIdList></Reference><Reference><Citation>Schinkel M., Boerman A.W., Bennis F.C., Minderhoud T.C., Lie M., Peters-Sengers H., Holleman F., Schade R.P., de Jonge R., Wiersinga W.J., et al. Diagnostic Stewardship for Blood Cultures in the Emergency Department: A Multicenter Validation and Prospective Evaluation of a Machine Learning Prediction Tool. eBioMedicine. 2022;82:104176. doi: 10.1016/j.ebiom.2022.104176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104176</ArticleId><ArticleId IdType="pmc">PMC9294655</ArticleId><ArticleId IdType="pubmed">35853298</ArticleId></ArticleIdList></Reference><Reference><Citation>Murri R., De Angelis G., Antenucci L., Fiori B., Rinaldi R., Fantoni M., Damiani A., Patarnello S., Sanguinetti M., Valentini V., et al. A Machine Learning Predictive Model of Bloodstream Infection in Hospitalized Patients. Diagnostics. 2024;14:445. doi: 10.3390/diagnostics14040445.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics14040445</ArticleId><ArticleId IdType="pmc">PMC10887662</ArticleId><ArticleId IdType="pubmed">38396484</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanzarella E.S., Vargas J., Menghini M., Postorino S., Pozzana F., Vallecoccia M.S., De Matteis F.L., Franchi F., Infante A., Larosa L., et al. An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients—C19-PNEUMOSCORE. J. Clin. Med. 2023;12:4688. doi: 10.3390/jcm12144688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12144688</ArticleId><ArticleId IdType="pmc">PMC10381000</ArticleId><ArticleId IdType="pubmed">37510807</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G., Lu J., Liu D., He Y. Characteristics and Risk Factors of Secondary Bacterial Infections in COVID-19 Patients. Antimicrob. Steward. Healthc. Epidemiol. 2023;3:e156. doi: 10.1017/ash.2023.425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ash.2023.425</ArticleId><ArticleId IdType="pmc">PMC10523549</ArticleId><ArticleId IdType="pubmed">37771749</ArticleId></ArticleIdList></Reference><Reference><Citation>Alosaimi B., Naeem A., Hamed M.E., Alkadi H.S., Alanazi T., Al Rehily S.S., Almutairi A.Z., Zafar A. Influenza Co-Infection Associated with Severity and Mortality in COVID-19 Patients. Virol. J. 2021;18:127. doi: 10.1186/s12985-021-01594-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01594-0</ArticleId><ArticleId IdType="pmc">PMC8200793</ArticleId><ArticleId IdType="pubmed">34127006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>